Journey Medical Corporation
DERM
$7.42
-$0.03-0.40%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 91.78% | 45.25% | -181.99% | 3.14% | -12.94% |
| Total Depreciation and Amortization | -8.66% | 5.80% | 8.47% | 29.75% | 29.44% |
| Total Amortization of Deferred Charges | -20.16% | -4.95% | 25.53% | 41.38% | 93.75% |
| Total Other Non-Cash Items | 59.33% | -32.87% | 61.90% | 62.73% | -50.82% |
| Change in Net Operating Assets | -625.90% | 296.38% | -444.88% | -265.68% | 116.51% |
| Cash from Operations | -84.08% | 202.72% | -382.43% | -105.96% | 81.80% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | 100.00% | -- |
| Issuance of Common Stock | -4.24% | -94.79% | -13.10% | 1,766.93% | 432.26% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -- | -- |
| Cash from Financing | -4.24% | -93.88% | -48.90% | 2,493.88% | -96.72% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -102.83% | 309.02% | 60.20% | 420.81% | -435.86% |